The premenstrual symptoms screening tool (PSST) for clinicians

@article{Steiner2003ThePS,
  title={The premenstrual symptoms screening tool (PSST) for clinicians},
  author={Meir Steiner and Mary Macdougall and Eileen B Brown},
  journal={Archives of Women’s Mental Health},
  year={2003},
  volume={6},
  pages={203-209}
}
Summary¶A variety of instruments have been used in an attempt to operationalize DSM-IV criteria for premenstrual dysphoric disorder (PMDD) and to understand clinically significant premenstrual syndrome (PMS. [...] Key Method Five hundred and nineteen women, between the ages of 18 and 55 yrs, who were seen at a primary care facility completed “The Premenstrual Symptoms Screening tool” (PSST). The PSST reflects and ‘translates’ categorical DSM-IV criteria into a rating scale with degrees of severity. The results…Expand
Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST).
  • Aline Henz, C. Ferreira, +5 authors M. C. Wender
  • Medicine
  • Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
  • 2018
TLDR
The PSST should be considered a diagnostic screening tool for premenstrual symptoms screening tool and positive PMS/PMDD cases by PS ST should be further evaluated by DRSP to confirm the diagnosis. Expand
Comparison of the Diagnostic Values of Premenstrual Syndrome Screening Tool (PSST) and Daily Record of Severity of Problems (DRSP)
TLDR
Premenstrual Symptoms Screening Tool could be a proper screening tool to identify normal women in clinical situations and diagnose mild PMS accurately, however, it is not an appropriate measure to predict the severity of PMS. Expand
Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women
TLDR
The results of this study suggest that race and ethnicity influence the expression of premenstrual symptoms and that the current state of medical care for Japanese women with moderate to severe PMS and PMDD is not satisfactory. Expand
The premenstrual tension syndrome rating scales: an updated version.
TLDR
By making minor modifications to the PMTS-O, this work has ensured that all criteria for the DSM-IV definition of PMDD are now represented in the PM TS-OR, and the newPMTS-VAS mirrors the PMts-OR but now also captures the severity of self rated symptoms. Expand
How to measure the impact of premenstrual symptoms? Development and validation of the German PMS-Impact Questionnaire
TLDR
The PMS-Impact Questionnaire was found to be a valid, reliable, and an economic measure to assess the impact of premenstrual symptoms and cross validations and confirmatory factor analyses should be conducted. Expand
Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder Aybaşi Öncesi Belirtileri Tarama Gereci: DSM-5 Aybaşi Öncesi Disfori Bozukluğunu Taramada Kullanişli bir Gereç
Aim: To assess the usefulness of Premenstrual Symptoms Screening Tool (PSST) in detecting Premenstrual Dysphoric Syndrome (PMDD) and Premenstrual Syndrome (PMS) in a Turkish sample. Material andExpand
Examination of premenstrual symptoms as a risk factor for depression in postpartum women
TLDR
It is suggested that premenstrual syndrome/premenstrual dysphoric disorder is an important risk factor for postpartum depression and women endorsing a history of PMS/PMDD should be monitored during the perinatal period. Expand
Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample
TLDR
Considering the association with poor physical health and high psychological distress, a broader underlying vulnerability in women qualifying for PMDD must be assumed and should be taken into account in clinical management as well as in future research in this field. Expand
Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool.
TLDR
The results demonstrate that the PMSIS has excellent discriminative ability to detect differences in groups that are known to differ in terms of clinical criteria, and can be used to educate consumers about the impact of their symptoms on QOL. Expand
Daily symptom ratings for studying premenstrual dysphoric disorder: A review.
TLDR
Prospective daily ratings of symptoms and related variables provide a valuable and important tool in the study of PMDD and the use of experience sampling and ecological momentary assessment is proposed to investigate within-person variability in symptoms in more detail. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 31 REFERENCES
The measurement of premenstrual mood symptoms.
TLDR
VASs in combination with the PMTS-O are low in burden to the client, reliable, valid and sensitive to change, and further refinement of these scales is warranted for classification and measurement of treatment effects in women diagnosed with premenstrual dysphoria. Expand
Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: The calendar of premenstrual experiences
TLDR
The calendar of premenstrual experiences luteal phase score distinguished PMS women from controls correctly in 104 of 108 cycles, with a 2.8% falsenegative rate and no false positives when used for two consecutive cycles. Expand
Reliability and validity of a daily diary for premenstrual syndrome
TLDR
The moderate correlations of the DSR with other standard symptom measures add to the evidence that PMS overlaps with other mood disorders at the premenstrual time but is not simply a brief depression or a truncated anxiety disorder. Expand
Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.
  • M. Steiner
  • Medicine
  • Journal of psychiatry & neuroscience : JPN
  • 2000
TLDR
Beyond conservative treatment options such as lifestyle and stress management, other non-antidepressant treatments, or the more extreme intervneitons that eliminate ovulation altogether, selective serotonin reuptake inhibitors (SSRIs) are emerging as the most effective treatment option. Expand
Prevalence, incidence and stability of premenstrual dysphoric disorder in the community
TLDR
In this sample of adolescents and young adults, premenstrual symptoms were widespread, but DSM-IV PMDD was considerably less prevalent and PMDD is a relatively stable and impairing condition, with high rates of health service utilization, increased suicidality and substantial co-morbidity. Expand
A design for studying the DSM-IV research criteria of premenstrual dysphoric disorder.
TLDR
Prospective data from a multiethnic sample of women were analyzed to develop an effective method of considering all DSM-IV research criteria for premenstrual dysphoric disorder, and prevalence estimates of the present study did not differ markedly from those in DSM- IV. Expand
Operationalizing DSM-IV criteria for PMDD: selecting symptomatic and asymptomatic cycles for research.
TLDR
No single operational threshold of the phenomenal features maximizes selection of both symptomatic and asymptomatic cycles, largely consequent to the ubiquity of post menstrual symptoms and premenstrual "interference" even in women without PMS. Expand
Severity of Premenstrual Symptoms in a Health Maintenance Organization Population
TLDR
The degree of premenstrual symptom severity varies in the population, is relatively constant within each woman over two consecutive cycles, particularly for emotional symptoms, and is influenced by age, race/ethnicity, and health status. Expand
Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior.
TLDR
The findings support the conclusion that premenstrual symptoms are common but do not usually interfere with functioning. Expand
The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France.
TLDR
There is significant unmet medical need in this more severely affected population of women and improved clinical identification of these women and increasing awareness of the efficacy of SSRIs in treating premenstrual symptomatology may be of benefit. Expand
...
1
2
3
4
...